
Loading, please wait...

Loading, please wait...

The intersection of aging and substance abuse presents unique clinical challenges for healthcare providers. Consequently, managing methamphetamine use in HIV requires a deep understanding of why older patients turn to stimulants. While younger users often prioritize sexual enhancement, older adults may use the drug to manage the physical and emotional tolls of chronic illness. Recent qualitative data suggests that clinicians must adapt their screening and intervention strategies to account for these shifting patient needs.
Furthermore, research indicates that motivations for use evolve significantly as patients age. Many older adults report using methamphetamine to maintain daily function or treat chronic symptoms like fatigue and pain. Additionally, social isolation often drives use as a coping mechanism. This shift from recreational to functional use complicates treatment because the drug becomes integrated into the patient\'s perceived self-care routine. Therefore, addressing the root causes of isolation and physical discomfort is essential for effective substance use intervention.
Clinically, methamphetamine use in HIV correlates with poor treatment outcomes and rapid disease progression. Specifically, chronic use can lead to severe neurocognitive impairment and cardiovascular complications. Moreover, many older adults lack awareness of overdose risks or harm reduction interventions. This gap in knowledge often results in continued use despite escalating physical harms and a personal desire to reduce consumption. Physicians should prioritize education on harm reduction and integrate behavioral therapies into standard HIV care protocols to mitigate these risks.
Stimulant use often leads to disorganized daily routines, which significantly impairs adherence to antiretroviral therapy (ART). This lack of consistency increases the risk of viral rebound and potential drug resistance.
Older patients often transition from using the drug for sexual pleasure to using it for energy to perform daily tasks, managing chronic pain, or coping with the loneliness associated with aging.
Many older adults view their use as a functional necessity rather than a recreational habit. Consequently, they often overlook traditional harm reduction services designed for younger or injection-based drug users.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice or a professional relationship. Always seek the advice of a qualified healthcare provider for any medical condition or treatment. Refer to the latest local and national guidelines for clinical practice.
References
Han BH et al. Methamphetamine Use Among Older Adults Living With HIV: A Qualitative Study. J Addict Med. 2026 Apr 16. doi: 10.1097/ADM.0000000000001691. PMID: 41985197.
Panda S, Roy T, Pahari S, et al. Emergence of cocaine and methamphetamine injection among HIV-positive injection drug users in Northern and Western India. Drug Alcohol Depend. 2014;135(1):160-165.
Blair CS, Shoptaw SJ. Managing Stimulant Use Among People With HIV: Harm-Reduction Strategies From Behavior to Medication. Top Antivir Med. 2024;32(4):534-541.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A qualitative study reveals that older adults with HIV often use methamphetamine to manage daily activities and chronic symptoms rather than for sexual plea...
4 months ago

A New York City initiative successfully distributed over 48,000 COVID-19 oral antiviral prescriptions through rapid home delivery in 2022. With 92% delivered within 24 hours, the program safeguarded vulnerable and elderly populations, establishing an equitable framework for emergency drug distribution.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today